![Infinity Pharmaceuticals logo](/static/img/stocks/infi.png)
Infinity Pharmaceuticals INFI
$ 0.04
-46.98%
Quarterly report 2023-Q2
added 08-10-2023
Country |
![]() |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Adelene Perkins |
Employees in the company |
25 |
Shares |
89.2 M |
Market Cap[1] |
$ 3.57 M |
EBITDA (LTM) |
$ -46 M |
P/E (LTM) |
-0.23 |
P/S (LTM) |
3.62 |
EPS (LTM) |
-0.48 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.